Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19

NCT04937543 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

50

Enrollment

OTHER

Sponsor class

Conditions

Covid19

Interventions

DRUG: inhaled beclametasone
DRUG: Inahaled beclomethasone / formoterol / glycopyrronium

Sponsor

UPECLIN HC FM Botucatu Unesp

Collaborators

[object Object]